{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:08:02Z","timestamp":1760242082328,"version":"build-2065373602"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.idc.2023.04.004","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T06:49:12Z","timestamp":1685602152000},"page":"577-591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mycobacteria in Organ Transplant Recipients"],"prefix":"10.1016","volume":"37","author":[{"given":"Niyati","family":"Narsana","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Alejandra P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aruna","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.idc.2023.04.004_bib1","doi-asserted-by":"crossref","first-page":"e13513","DOI":"10.1111\/ctr.13513","volume":"33","author":"Subramanian","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib2","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/14787210.2020.1704255","article-title":"Prevention and treatment of tuberculosis in solid organ transplant recipients","volume":"18","author":"Abad","year":"2020","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib3","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.idc.2018.05.002","article-title":"Prevention and Management of Tuberculosis in Solid Organ Transplant Recipients","volume":"32","author":"Epstein","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"12","key":"10.1016\/j.idc.2023.04.004_bib4","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1086\/599035","article-title":"Tuberculosis after solid-organ transplant: incidence, risk factors, and clinical characteristics in the RESITRA (Spanish Network of Infection in Transplantation) cohort","volume":"48","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.idc.2023.04.004_bib5","doi-asserted-by":"crossref","first-page":"3041","DOI":"10.1016\/j.transproceed.2005.07.041","article-title":"Preliminary report of a nationwide case-control study for identifying risk factors of tuberculosis following renal transplantation","volume":"37","author":"Basiri","year":"2005","journal-title":"Transplant Proc"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib6","doi-asserted-by":"crossref","first-page":"e13729","DOI":"10.1111\/tid.13729","article-title":"Incidence rate of active tuberculosis in solid organ transplant recipients: Data from a nationwide population cohort in a high-endemic country","volume":"23","author":"Kwon","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib7","doi-asserted-by":"crossref","first-page":"e13566","DOI":"10.1111\/tid.13566","article-title":"Risk factors and clinical outcomes of tuberculosis among kidney transplant recipients in high endemic country","volume":"23","author":"Thitisuriyarax","year":"2021","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib8","doi-asserted-by":"crossref","first-page":"e13800","DOI":"10.1111\/tid.13800","article-title":"Donor-derived tuberculosis among solid organ transplant recipients in the United States-2008 to 2018","volume":"24","author":"Malinis","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"8","key":"10.1016\/j.idc.2023.04.004_bib9","doi-asserted-by":"crossref","first-page":"e13643","DOI":"10.1111\/ctr.13643","article-title":"Tests for latent tuberculosis in candidates for solid organ transplantation: A systematic review and meta-analysis","volume":"33","author":"Maung Myint","year":"2019","journal-title":"Clin Transplant"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2012.07.019","article-title":"Tests for latent tuberculosis in people with ESRD: a systematic review","volume":"61","author":"Rogerson","year":"2013","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib11","doi-asserted-by":"crossref","first-page":"e12845","DOI":"10.1111\/tid.12845","article-title":"Tuberculosis after liver transplantation in a large center in New York City: QuantiFERON\u00ae -TB Gold-based pre-transplant screening performance and active tuberculosis post-transplant","volume":"20","author":"Hand","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"12","key":"10.1016\/j.idc.2023.04.004_bib12","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/j.1600-6143.2007.02011.x","article-title":"Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation","volume":"7","author":"Manuel","year":"2007","journal-title":"Am J Transplant"},{"issue":"8","key":"10.1016\/j.idc.2023.04.004_bib13","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1002\/lt.22319","article-title":"Chest computed tomography is more likely to show latent tuberculosis foci than simple chest radiography in liver transplant candidates","volume":"17","author":"Lyu","year":"2011","journal-title":"Liver Transpl"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib14","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/tid.12555","article-title":"Risk of tuberculosis after lung transplantation: the value of pretransplant chest computed tomography and the impact of mTOR inhibitors and azathioprine use","volume":"18","author":"Guirao-Arrabal","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.04.004_bib15","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1111\/j.1600-6143.2012.04205.x","article-title":"Diagnosis and management of tuberculosis in transplant donors: a donor-derived infections consensus conference report [published correction appears in Am J Transplant. 2013 Feb;13(2):528]","volume":"12","author":"Morris","year":"2012","journal-title":"Am J Transplant"},{"issue":"9","key":"10.1016\/j.idc.2023.04.004_bib16","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/ajt.12787","article-title":"Comparative analysis of assays for detection of cell-mediated immunity toward cytomegalovirus and M. tuberculosis in samples from deceased organ donors","volume":"14","author":"Schmidt","year":"2014","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib17","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.4103\/1319-2442.144258","article-title":"Performance of QuantiFERON TB Gold test in detecting latent tuberculosis infection in brain-dead organ donors in Iran: a brief report","volume":"25","author":"Tabarsi","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib18","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/TP.0000000000001329","article-title":"Twelve-Week Rifapentine Plus Isoniazid Versus 9-Month Isoniazid for the Treatment of Latent Tuberculosis in Renal Transplant Candidates","volume":"101","author":"Simkins","year":"2017","journal-title":"Transplantation"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib19","doi-asserted-by":"crossref","first-page":"e13178","DOI":"10.1111\/tid.13178","article-title":"Treatment of latent TB Infection and the risk of tuberculosis after solid organ transplantation: Comprehensive review","volume":"21","author":"Abad","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"19","key":"10.1016\/j.idc.2023.04.004_bib20","doi-asserted-by":"crossref","first-page":"5760","DOI":"10.3748\/wjg.v20.i19.5760","article-title":"Antitubercular therapy in patients with cirrhosis: challenges and options","volume":"20","author":"Kumar","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"8","key":"10.1016\/j.idc.2023.04.004_bib21","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1002\/lt.21709","article-title":"Tuberculosis in liver transplant recipients: a systematic review and meta-analysis of individual patient data","volume":"15","author":"Holty","year":"2009","journal-title":"Liver Transpl"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1378\/chest.99.2.465","article-title":"Toxic hepatitis with isoniazid and rifampin. A meta-analysis","volume":"99","author":"Steele","year":"1991","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib23","doi-asserted-by":"crossref","first-page":"e13849","DOI":"10.1111\/tid.13849","article-title":"Isoniazid prophylaxis in liver transplant recipient with latent tuberculosis: Is it harmful for transplanted liver?","volume":"24","author":"Ghayumi","year":"2022","journal-title":"Transpl Infect Dis"},{"issue":"11","key":"10.1016\/j.idc.2023.04.004_bib24","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/cid\/civ156","article-title":"Tuberculosis prophylaxis with levofloxacin in liver transplant patients is associated with a high incidence of tenosynovitis: safety analysis of a multicenter randomized trial","volume":"60","author":"Torre-Cisneros","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.idc.2023.04.004_bib25","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1086\/514993","article-title":"Mycobacterium tuberculosis infection in solid-organ transplant recipients: impact and implications for management","volume":"27","author":"Singh","year":"1998","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S2213-2600(16)00048-5","article-title":"Genome-wide expression for diagnosis of pulmonary tuberculosis: a multicohort analysis","volume":"4","author":"Sweeney","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib27","doi-asserted-by":"crossref","first-page":"e183779","DOI":"10.1001\/jamanetworkopen.2018.3779","article-title":"Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response","volume":"1","author":"Warsinske","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib28","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/MAJ.0b013e31814a586a","article-title":"Update on rifampin and rifabutin drug interactions","volume":"335","author":"Baciewicz","year":"2008","journal-title":"Am J Med Sci"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib29","first-page":"76","article-title":"Review of Pharmacologic Considerations in the Use of Azole Antifungals in Lung Transplant Recipients","volume":"7","author":"Klatt","year":"2021","journal-title":"J\u00a0Fungi (Basel)"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib30","doi-asserted-by":"crossref","first-page":"e13259","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: A review of more than 2000 cases","volume":"32","author":"Abad","year":"2018","journal-title":"Clin Transplant"},{"issue":"20","key":"10.1016\/j.idc.2023.04.004_bib31","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.2169\/internalmedicine.5300-20","article-title":"Identification and Characteristics of Co-isolation of Multiple Nontuberculous Mycobacteria","volume":"60","author":"Asaoka","year":"2021","journal-title":"Intern Med"},{"issue":"11","key":"10.1016\/j.idc.2023.04.004_bib32","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1164\/rccm.201501-0067OC","article-title":"Comparison of Clinical Features, Virulence, and Relapse among Mycobacterium avium Complex Species","volume":"191","author":"Boyle","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib33","doi-asserted-by":"crossref","first-page":"318","DOI":"10.17843\/rpmesp.2021.382.6108","article-title":"[Clinical behavior of infection and disease caused by non-tuberculous mycobacteria in Latin America: Scoping review]","volume":"38","author":"Mora","year":"2021","journal-title":"Rev Peru Med Exp Salud P\u00fablica"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib34","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciaa241","article-title":"Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS\/ERS\/ESCMID\/IDSA Clinical Practice Guideline","volume":"71","author":"Daley","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib35","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.idc.2018.04.011","article-title":"Management of Mycobacterium Other than Tuberculosis in Solid Organ Transplantation","volume":"32","author":"Malinis","year":"2018","journal-title":"Infect Dis Clin North Am"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib36","doi-asserted-by":"crossref","first-page":"e995","DOI":"10.1093\/cid\/ciac608","article-title":"Risk factors for Nontuberculous Mycobacteria Infections in Solid Organ Transplant recipients: a multinational case-control study [published online ahead of print, 2022 Jul 26]","volume":"76","author":"Mejia-Chew","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib37","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmi.2014.07.001","article-title":"Non-tuberculous mycobacterial infections after solid organ transplantation: a survival analysis","volume":"21","author":"Longworth","year":"2015","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib38","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1055\/s-0041-1727250","article-title":"Mycobacteria: Selection of Transplant Candidates and Post-lung Transplant Outcomes","volume":"42","author":"Friedman","year":"2021","journal-title":"Semin Respir Crit Care Med"},{"issue":"7","key":"10.1016\/j.idc.2023.04.004_bib39","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1093\/cid\/ciw877","article-title":"Two-Phase Hospital-Associated Outbreak of Mycobacterium abscessus: Investigation and Mitigation","volume":"64","author":"Baker","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib40","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jiac.2019.11.004","article-title":"Mycobacterium chimaera infections: An update","volume":"26","author":"Riccardi","year":"2020","journal-title":"J\u00a0Infect Chemother"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib41","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11908-018-0619-8","article-title":"Non-tuberculous Mycobacterial Infections in Thoracic Transplant Candidates and Recipients","volume":"20","author":"Rao","year":"2018","journal-title":"Curr Infect Dis Rep"},{"issue":"7","key":"10.1016\/j.idc.2023.04.004_bib42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.healun.2011.02.007","article-title":"Non-tuberculous mycobacterium infection after lung transplantation is associated with increased mortality","volume":"30","author":"Huang","year":"2011","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"7","key":"10.1016\/j.idc.2023.04.004_bib43","doi-asserted-by":"crossref","first-page":"ofac254","DOI":"10.1093\/ofid\/ofac254","article-title":"Mycobacterium abscessus Infections in Solid Organ Transplant Recipients: Single-Center Experience in the United States, 2013-2018","volume":"9","author":"Ebisu","year":"2022","journal-title":"Open Forum Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib44","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/tid.12546","article-title":"Analysis of pulmonary non-tuberculous mycobacterial infections after lung transplantation","volume":"18","author":"Shah","year":"2016","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib45","doi-asserted-by":"crossref","first-page":"e12835","DOI":"10.1111\/tid.12835","article-title":"Mycobacterium abscessus infections in lung transplant recipients: 15-year experience from a single institution","volume":"20","author":"Osmani","year":"2018","journal-title":"Transpl Infect Dis"},{"issue":"9","key":"10.1016\/j.idc.2023.04.004_bib46","doi-asserted-by":"crossref","first-page":"e13588","DOI":"10.1111\/ctr.13588","article-title":"Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Longworth","year":"2019","journal-title":"Clin Transplant"},{"issue":"11","key":"10.1016\/j.idc.2023.04.004_bib47","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1099\/ijsem.0.003026","article-title":"A\u00a0definition of the Mycobacterium avium complex for taxonomical and clinical purposes, a review","volume":"68","author":"Van Ingen","year":"2018","journal-title":"Int J Syst Evol Microbiol"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib48","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/aje\/kwj159","article-title":"Environmental risk factors for infection with Mycobacterium avium complex","volume":"164","author":"Reed","year":"2006","journal-title":"Am J Epidemiol"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib49","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.transproceed.2012.02.035","article-title":"Nontuberculous mycobacterial disease is not a contraindication to lung transplantation in patients with cystic fibrosis: a retrospective analysis in a Danish patient population","volume":"45","author":"Qvist","year":"2013","journal-title":"Transplant Proc"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib50","doi-asserted-by":"crossref","first-page":"e13084","DOI":"10.1111\/tid.13084","article-title":"Management and clinical outcomes after lung transplantation in patients with pre-transplant Mycobacterium abscessus infection: A single center experience","volume":"21","author":"Perez","year":"2019","journal-title":"Transpl Infect Dis"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib51","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/ctr.12140","article-title":"Lung transplant outcomes in cystic fibrosis patients with pre-operative Mycobacterium abscessus respiratory infections","volume":"27","author":"Lobo","year":"2013","journal-title":"Clin Transplant"},{"issue":"4","key":"10.1016\/j.idc.2023.04.004_bib52","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.ccm.2017.07.011","article-title":"Mycobacterial Infections in Solid Organ and Hematopoietic Stem Cell Transplantation","volume":"38","author":"Pena","year":"2017","journal-title":"Clin Chest Med"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3201\/eid2703.201087","article-title":"Extrapulmonary Nontuberculous Mycobacteria Infections in Hospitalized Patients, United States, 2009-2014","volume":"27","author":"Ricotta","year":"2021","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib54","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1399-3062.2009.00432.x","article-title":"Mycobacterium avium-intracellulare-associated acute interstitial nephritis: a rare cause of renal allograft dysfunction","volume":"11","author":"Rawla","year":"2009","journal-title":"Transpl Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib55","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1399-3062.2010.00521.x","article-title":"Successful management of primary nontuberculous mycobacterial infection of hepatic allograft following orthotopic liver transplantation for hepatitis C","volume":"13","author":"Singhal","year":"2011","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idc.2023.04.004_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jctube.2016.04.001","article-title":"Non-tuberculous mycobacterial infections in solid organ transplant recipients: An update","volume":"4","author":"Abad","year":"2016","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"key":"10.1016\/j.idc.2023.04.004_bib57","doi-asserted-by":"crossref","first-page":"100244","DOI":"10.1016\/j.jctube.2021.100244","article-title":"Approach to the diagnosis and treatment of non-tuberculous mycobacterial disease","volume":"24","author":"Pennington","year":"2021","journal-title":"J\u00a0Clin Tuberc Other Mycobact Dis"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib58","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/infdis\/166.2.405","article-title":"Skin, soft tissue, and bone infections due to Mycobacterium chelonae chelonae: importance of prior corticosteroid therapy, frequency of disseminated infections, and resistance to oral antimicrobials other than clarithromycin","volume":"166","author":"Wallace","year":"1992","journal-title":"J\u00a0Infect Dis"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib59","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.det.2015.03.017","article-title":"Nontuberculous Mycobacteria: Skin and Soft Tissue Infections","volume":"33","author":"Gonzalez-Santiago","year":"2015","journal-title":"Dermatol Clin"},{"issue":"9","key":"10.1016\/j.idc.2023.04.004_bib60","doi-asserted-by":"crossref","first-page":"e0021722","DOI":"10.1128\/jcm.00217-22","article-title":"Evaluation of MALDI Biotyper Mycobacteria Library for Identification of Nontuberculous Mycobacteria","volume":"60","author":"Toney","year":"2022","journal-title":"J\u00a0Clin Microbiol"},{"issue":"6","key":"10.1016\/j.idc.2023.04.004_bib61","doi-asserted-by":"crossref","first-page":"e00470","DOI":"10.1128\/AAC.00470-19","article-title":"In\u00a0Vitro Activity of New Tetracycline Analogs Omadacycline and Eravacycline against Drug-Resistant Clinical Isolates of Mycobacterium abscessus","volume":"63","author":"Kaushik","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idc.2023.04.004_bib62","doi-asserted-by":"crossref","first-page":"e01798","DOI":"10.1128\/AAC.01798-16","article-title":"In\u00a0Vitro Susceptibility Testing of Bedaquiline against Mycobacterium avium Complex","volume":"61","author":"Brown-Elliott","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"10.1016\/j.idc.2023.04.004_bib63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/cid\/ciq237","article-title":"Clinical and microbiologic outcomes in patients receiving treatment for Mycobacterium abscessus pulmonary disease","volume":"52","author":"Jarand","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.idc.2023.04.004_bib64","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.chest.2021.07.035","article-title":"Treatment of Mycobacterium abscessus Pulmonary Disease","volume":"161","author":"Griffith","year":"2022","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.idc.2023.04.004_bib65","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1093\/cid\/ciw723","article-title":"Progression and Treatment Outcomes of Lung Disease Caused by Mycobacterium abscessus and Mycobacterium massiliense","volume":"64","author":"Park","year":"2017","journal-title":"Clin Infect Dis"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000405?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552023000405?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T15:33:31Z","timestamp":1760196811000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552023000405"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0891552023000405"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2023.04.004","relation":{},"ISSN":["0891-5520"],"issn-type":[{"type":"print","value":"0891-5520"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycobacteria in Organ Transplant Recipients","name":"articletitle","label":"Article Title"},{"value":"Infectious Disease Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idc.2023.04.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}